CLINICAL_TRIALS
other
· 2025-07-03
Clinical Trial Update: Connect® Myeloid Disease Registry
Summary
The Connect Myeloid Disease Registry sponsored by Celgene has been terminated. The registry involved conditions including primary myelofibrosis, myelodysplastic…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Celgene | Conditions: Primary Myelofibrosis, Myelodysplastic Syndromes | Status: TERMINATED